Table 5.
Associations between pulmonary versus nonpulmonary infection and 60-day mortality of acute respiratory distress syndrome
Survivors (n = 337) |
Nonsurvivors (n = 212) |
ARDS mortality (%) |
Adjusted HR(95% CI)a | P value | |
---|---|---|---|---|---|
Pulmonary infection | 210 | 123 | 36.9 | 1.0 | |
Nonpulmonary infection | 77 | 48 | 38.4 | 1.26 (0.87–1.85) | 0.226 |
Combined pulmonary and nonpulmonary infections | 50 | 41 | 45.1 | 1.69 (1.14–2.49) | 0.008 |
ARDS infection-related acute respiratory distress syndrome, HR hazard ratio, CI confidence interval
Multivariate Cox regression analyses stratified by calendar year, adjusted for age, gender, ethnicity, APACHE III score, body mass index, bacteremia, liver cirrhosis/failure, metastatic/hematological malignancies, pre-ICU stay ≥48 h, PEEP level used on the first day of ARDS diagnosis, vasopressors used on the first day of ARDS diagnosis, and treatment with activated protein C